TABLE 3.
Variable | R2 | P-value |
Treatment (M-16V or Control) | 0.238 | 0.009** |
Gestational age (<30 or ≥ 30 weeks) | 0.035 | 0.459 |
Birth weight (<1,200 or ≥1,200 g) | 0.076 | 0.183 |
Discharge weight (<3,000 or ≥3,000 g) | 0.036 | 0.444 |
Hospitalization period (<10 or ≥10 weeks) | 0.029 | 0.527 |
Postnatal age at the fecal sampling (<16 or ≥ 16 weeks) | 0.026 | 0.565 |
Corrected age at the fecal sampling (<7 or ≥7 weeks) | 0.016 | 0.746 |
Fecal sampling (<5 or ≥5 weeks after discharge) | 0.019 | 0.692 |
Residuals | 0.524 | |
Total | 1.000 |
The PERMANOVA multivariate analysis was performed using a weighted UniFrac matrix.
**P < 0.01.